← Leaderboards
Paige Kaplan
Childrens Hospital Of Philadelphia
$34,549
Attributed
$34,549
Total exposure
3
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$34,549 · 3
By mechanism
M01$34,549 · 3
Top collaborators
No co-investigators on record.
Most similar at Childrens Hospital Of Philadelphia
Same institution · by research overlap
- Nataliya Zelikovsky$12,682
- Rebecca A Finkel$22,893
Others in their field
Top investigators on “Patient Oriented Research”
- Praduman Jain · Vignet, Inc.$103,566,231
- Larry Arthur$103,000,000
- Charles A Coltman · Southwest Oncology Group$87,961,334
- Gregory H Reaman · National Childhood Cancer Foundation$61,988,461
- Steven E Reis · University Of Pittsburgh At Pittsburgh$61,626,874
- Steven M. Dubinett · Va Greater Los Angeles Healthcare System$57,862,577
Research focus
Patient Oriented ResearchEnzyme TherapyDrug Screening /EvaluationClinical ResearchRecombinant ProteinsHuman SubjectHuman Therapy EvaluationEnzyme ActivityInjection /InfusionKidney Disorder ChemotherapyLongitudinal Human StudyMetabolism Disorder ChemotherapyMucopolysaccharidosis Type IO GlycosidasePathologic ProcessPharmacokineticsPlacebosPrognosisRespiratory Airway VolumeTime Resolved DataAlpha GalactosidaseUrinalysisBlood TestsClinical Trials
Grant awards (4)
STUDY OF RECOMBINANT HUMAN ALPHA-L-IDURONIDASE IN MPSI$25,373
M01 · FY2005 · RR
RECOMBINANT HUMAN N-ACETYLGALACTOSAMINE-4-SULFATASE (RHASB) IN MPS VI$1,290
M01 · FY2005 · RR
Study of recombinant human alpha-L-iduronidase in MPSI$5,566
M01 · FY2004 · RR
Recombinant human a Galactosidase A on renal disease in Fabry disease$2,320
M01 · FY2004 · RR